Introduction
Bonsai, which contains various different synthetic cannabinoids (SCs) is widely used by young people because it is cheaper and more easily available than narcotic drug,marijuana and cocaine (1) . The most common side effects are sweating, tachycardia, tremor, nausea, vomiting, hyper/hypotension, agitation, confusion, and respiratory depression.
This report describes the case of a patient with respiratory depression and acute respiratory distress syndrome (ARDS) developing following bonsai use and subsequent pneumothorax. It also discusses the side effects of bonsai use in the respiratory system and provides information from the literature.
Case Presentation
A 25-year-old male was found unconscious at home by relatives and was brought to a nearby emergency department. At his initial examination, his general condition was poor and he was unconscious. Respiratory arrest developed, and he was intubated. SC intoxication and respiratory failure were diagnosed in light of the history of bonsai use. On the second day, he was referred to our university hospital intensive care unit from the state hospital. Mechanical ventilatory support was administered. Widespread bilateral infiltration was observed on the posteroanterior chest radiography on the second day of hospitalization. On the second day, his blood gas pH was 7.18, arterial partial pressure of oxygen (PaO 2 ) was 140 mmHg, arterial partial pressure of carbon dioxide (PaCO 2 ) was 65 mmHg, bicarbonate (HCO 3 ) was 18 mmol/Land oxygenation index (PaO 2 /FiO 2 )was 140 mmHg; in the light of the sudden onset, bonsai intoxication-related ARDS was suspected. The mechanical ventilator employed due to ARDS was adjusted to a tidal volume of 5-7 mg/kg, high positive end-expiratory pressure (PEEP) and daily blood gas values. On the eight day of hospitalization, his GCS score was 14, blood gas pH was 7.39, PaO 2 was 260 mmHg, PaCO 2 was 43 mmHg, HCO 3 was 26 mmol/Land PaO 2 /FiO 2 was 577 mmHg. A sufficient tidal volume was achieved at low pressures. The patient met the weaning criteria and was extubated. Sudden-onset respiratory difficulty and chest pain developed the following day. Posteroanterior chest radiography was performed. Pneumothorax was detected in the left lung, and tube thoracostomy was performed (Fig-ure 1) . The drain tube was removed in the absence of air leakage from the drain; pneumothorax was not seen on performing control radiography (Figure 2 ). His GCS score was 15, and his general condition was good and vital findings were stable. There was no respiratory difficulty, and he was discharged in a healthy condition on the 11 th day of hospitalization.
Discussion
SCs were initially used in Europe and then gradually spread worldwide (2). The American Association of Poison Control Centers reported 53 cases of exposure to bonsai in 2009 and 13,000 cases in 2011 (3). This increase is responsible for tremendous increase in bonsai use in Turkey, despite the absence of official figures to date. We attribute this increase to the low cost of bonsai and its easy availability that is associated with the absence of supervision among the young, urban population.
Similar to marijuana, the chronic use of SCs leads to dependence syndrome, withdrawal symptoms, and psychiatric symptoms (1) . However, in contrast to marijuana, acute intoxication findings more closely resemble those seen during sympathomimetic drug use. Despite frequent side effects involving the cardiopulmonary system, such as hyper/hypotension, confusion, and respiratory depression, clinical symptoms and presentations can vary. In the management of SC toxicity, supportive treatment, such as fluid and electrolyte replacement, benzodiazepines for agitation and anxiety, and non-invasive or invasive ventilatory support for respiratory failure, has been suggested (4, 5) .
In a study in Turkey, Köklü et al. (6) reported myocardial infarction following bonsai use. In our case, respiratory arrest following bonsai use and pneumothorax developed after ARDS. We attribute this to SCs causing toxic injury to the pulmonary parenchymal tissue. SCs causing vasoconstriction and endothelial dysfunction and resulting in injury by creating nutrition problems in the peripheral pulmonary parenchyma may account for the pathophysiology of the respiratory side effects in our patient. Kaya et al. (5) reported a decrease in clinical findings at the 3-h observation after bonsai use. However, this may vary depending on the variety of SCs in the bonsai used and the intake amount. The pulmonary complications developing in our patient persisted until the 10 th day after substance use. Therefore, we think that it is important for physicians who monitor such patients to keep the monitoring or hospitalization period relatively lengthy to be able to recognize such potential complications.
Conclusion
Severe respiratory depression and ARDS can develop in association with bonsai use. The development of pneumothorax can be a complication of respiration with mechanical ventilation in ARDS patients. The close monitoring of respiratory functions during the monitoring of such patients and the careful evaluation of pulmonary X-rays will permit the early diagnosis and treatment of pulmonary complications. 
